Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetrexate vs Standard Therapy vs Standard Therapy + Steroids for Refractory PCP in AIDS
NCT00000730Phase 3Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of trimetrexate glucuronate, methylprednisolone in pneumocystis pneumonia (PCP), sponsored by National Institute of Allergy and Infectious Diseases. Status: terminated.
02
Drugs
trimetrexate glucuronatemethylprednisolone
03
Conditions
pneumocystis pneumonia (PCP)
Beyond the preview
Go deeper on NCT00000730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000730.